Send feedback

SZT2 p.Ala1326Val

c.3977C>T · rs747241860 · VCV433088

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 2 submitters
AlphaMissense
likely pathogenic
0.6368 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00381%, nfe)
Missense predictors
2/2 damaging
AlphaMissense, REVEL
Conditions
1
self-limited epilepsy with centrotemporal spikes

Computational evidence

Protein change
AlphaMissense0.6368likely pathogenic
REVEL0.647pathogenic-leaning
⇒ AlphaMissense and REVEL both call this damaging.
Splicing
SpliceAI<0.2all four deltas below 0.2 · C>A here scores Δ0.59 · evaluated, not missing
Constraint at this position
ConservationphyloP 7.6GERP 1.7, phastCons 1
Regional constrainto/e 0.92unconstrained · MANE · 15 kb · p 0.00032 · regional, not allelic
Overall
CADD28.4PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00381% European (non-Finnish) · 45/1,180,024 alleles
Filtering AF 0.00291% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0026%
Overall 0.00347% 56/1,614,032 alleles · very rare
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.00937% 10,672
Remaining individualsnot grpmax-eligible 0.0048% 20,829
European (non-Finnish)grpmax 0.00381% 26,223
East Asian 0.00223% 44,892
South Asian 0.0011% 91,090

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SZT2
Protein
p.Ala1326Val
Coding
c.3977C>T
MANE Select
NM_001365999
dbSNP
rs747241860
Type
single nucleotide variant
Location
chr1:43428297 (GRCh38)
Gene constraint
LOEUF 0.582 · pLI <0.01 (gnomAD)
Residue 1326
a UniProt-annotated variant site (in dee18)
Full SZT2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

self-limited epilepsy with centrotemporal spikes — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Self-limited epilepsy with centrotemporal spikes (Orphanet):

Inheritance
Autosomal dominant
Onset
Childhood

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/szt2-p-ala1326val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown